UK: Foundation approvals on hold as industry awaits review report
This article was originally published in Clinica
Executive Summary
This month saw another six UK National Health Service trusts gain foundation status, bringing the total to 31. The government remains committed to ensuring that all trusts - some 300 - will be eligible to apply for foundation status by 2008, but in their way stand significant commercial and tariff-related problems. While some have surfaced in the form of serious financial management issues for the new foundation trusts themselves, the issues also have significant repercussions for the medical technology industry (see Clinica No 1150, p 7).
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.